YKL-40 expression in pterygium: a potential role in the pathogenesis
- PMID: 29922975
- DOI: 10.1007/s10792-018-0957-4
YKL-40 expression in pterygium: a potential role in the pathogenesis
Abstract
Purpose: The aim of the study was to evaluate whether YKL-40 (chitinase 3-like 1 protein) plays a role in pterygium pathogenesis.
Methods: We included 42 primary pterygium patients and 24 control subjects with normal bulbar conjunctiva in the study. The pterygium patients were classified into the atrophic, fleshy, and intermediate groups according to the Tan classification. We then surgically removed the primary nasal pterygium and normal bulbar conjunctiva from the patients and immunohistochemically investigated YKL-40 expression.
Results: YKL-40 expression was statistically significantly higher in the epithelial, endothelial, and stromal cells of the pterygium tissues than in the control tissues (P = 0.009, P = 0.003, P = 0.002, respectively). There was no significant correlation between the pterygium subgroups and YKL-40 expression (P > 0.05).
Conclusions: We believe YKL-40 may play a significant role in pterygium pathogenesis.
Keywords: Angiogenesis; Inflammation; Pterygium; YKL-40.
Similar articles
-
Endocan Overexpression in Pterygium.Cornea. 2017 Jun;36(6):696-699. doi: 10.1097/ICO.0000000000001183. Cornea. 2017. PMID: 28410547
-
Overexpression of fractalkine and its histopathological characteristics in primary pterygium.Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2743-2750. doi: 10.1007/s00417-019-04463-3. Epub 2019 Oct 21. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31637486
-
Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.Mol Vis. 2011;17:1687-93. Epub 2011 Jun 23. Mol Vis. 2011. PMID: 21738398 Free PMC article.
-
Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):607-15. doi: 10.1177/039463201202500307. Int J Immunopathol Pharmacol. 2012. PMID: 23058011 Review.
-
Pharmacological treatment strategies of pterygium: Drugs, biologics, and novel natural products.Drug Discov Today. 2023 Jan;28(1):103416. doi: 10.1016/j.drudis.2022.103416. Epub 2022 Oct 22. Drug Discov Today. 2023. PMID: 36280041 Review.
Cited by
-
The Association of MMP7 Genotype With Pterygium.In Vivo. 2020 Jan-Feb;34(1):51-56. doi: 10.21873/invivo.11744. In Vivo. 2020. PMID: 31882462 Free PMC article.
-
Evaluation of Neutrophil-Lymphocyte Ratios, Mean Platelet Volumes, and Platelet-Lymphocyte Ratios in Pterygium.Beyoglu Eye J. 2019 Dec 25;4(3):163-167. doi: 10.14744/bej.2019.30164. eCollection 2019. Beyoglu Eye J. 2019. PMID: 35187453 Free PMC article.
-
Potential Role of Malassezia restricta in Pterygium Development.Int J Mol Sci. 2025 Mar 25;26(7):2976. doi: 10.3390/ijms26072976. Int J Mol Sci. 2025. PMID: 40243577 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources